콘텐츠로 건너뛰기
Merck
  • Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.

Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.

Cutis (1997-06-01)
J C Santoso-Pham, E D Shelley, W B Shelley
초록

Keratoacanthoma is a common skin tumor characterized by rapid growth of a smooth dome-shaped nodule with a central plug of keratin, usually followed by spontaneous involution. We report the case of a giant keratoacanthoma on the face that continued to spread peripherally for several months despite vigorous therapeutic intervention. Treatment with methotrexate (25 mg intramuscularly) and Kenalog (triamcinolone acetonide, 40 mg intramuscularly) weekly finally slowed and stopped the expanding, deforming tumor growth and induced involution.

MATERIALS
제품 번호
브랜드
제품 설명

Triamcinolone, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Triamcinolone